INSIDERFilingvia Quantisnow
180 Life Sciences Corp. logo

180 Life Sciences (ATNF) executive Rothbard received 24,307 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Jonathan B. Rothbard (executive at 180 Life Sciences Corp., ATNF) reported that they received 24,307 shares on Apr 7, 2021. After these transactions the filing shows 560,449 shares held directly.

Reporting person
Rothbard Jonathan B.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Apr 7, 2021Grant or award (A)Common Stock1+24,307$6.14$149K560,449 direct

Holdings before and after

  • Common Stock: 536,142 to 560,449 direct

Footnotes from the filing

  1. 1. Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Rothbard report in this ATNF Form 4?

Jonathan B. Rothbard (executive at 180 Life Sciences Corp., ATNF) reported that they received 24,307 shares on Apr 7, 2021. After these transactions the filing shows 560,449 shares held directly.

How many ATNF shares does Rothbard hold after this filing?

The filing shows 560,449 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Ask Ellis, your AI research assistant, about this story

Historical context for ATNF

Earlier insider filings at ATNF

Keep researching ATNF

Quantisnow market dataNASDAQ
180 Life Sciences Corp. logo
ATNF
180 Life Sciences Corp.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2017
Get push alerts for ATNF

Follow ATNF and get a push notification the moment its next story breaks.

Full ATNF profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATNF (180 Life Sciences Corp.) and more on Quantisnow.